HIV vaccine hunt: Four-Way trial seeks best shot
NCT ID NCT02038842
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 31 times
Summary
This study tested four different HIV vaccine combinations in 92 healthy volunteers at low risk of HIV. The goal was to find which combination is safest and best at triggering the body's immune defenses against HIV. Researchers used a 'prime-boost' approach, giving an initial shot followed by a booster to strengthen the response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service d'Immunologie Clinique 51, avenue du Marechal de Lattre de Tassigny
Créteil, 94010, France
Conditions
Explore the condition pages connected to this study.